Rigel Pharmaceuticals (RIGL) News Today → The 2024 Gold Rush: Unleashing Market Potential (From Priority Gold) (Ad) Free RIGL Stock Alerts $0.99 -0.20 (-16.77%) (As of 05/8/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineRigel Pharmaceuticals, Inc.: Rigel Reports First Quarter 2024 Financial Results and Provides Business Updatefinanznachrichten.de - May 8 at 6:37 PMBuy Rating Affirmed on Rigel’s Consistent Performance and Growth Prospectsmarkets.businessinsider.com - May 8 at 6:37 PMRigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q1 2024 Earnings Call Transcriptfinance.yahoo.com - May 8 at 6:37 PMRigel Pharmaceuticals (NASDAQ:RIGL) Receives Buy Rating from HC Wainwrightmarketbeat.com - May 8 at 10:13 AMRigel Pharmaceuticals (NASDAQ:RIGL) Issues Quarterly Earnings Results, Misses Estimates By $0.02 EPSmarketbeat.com - May 8 at 8:41 AMRigel Pharmaceuticals Inc (RIGL) Q1 2024 Earnings Call Transcript Highlights: Strategic Moves ...finance.yahoo.com - May 8 at 8:34 AMRIGL Stock Earnings: Rigel Pharmaceuticals Misses EPS, Misses Revenue for Q1 2024investorplace.com - May 7 at 10:05 PMRigel Pharmaceuticals Inc. Q1 Loss decreases, but misses estimatesmarkets.businessinsider.com - May 7 at 5:17 PMRigel Reports First Quarter 2024 Financial Results and Provides Business Updateprnewswire.com - May 7 at 4:01 PMRigel Pharmaceuticals is about to announce earnings — here's what Wall Street expectsmarkets.businessinsider.com - May 7 at 7:15 AMRigel Pharmaceuticals (RIGL) to Release Quarterly Earnings on Tuesdayamericanbankingnews.com - May 5 at 6:50 AMRigel Pharmaceuticals (RIGL) to Release Earnings on Tuesdaymarketbeat.com - May 1 at 10:58 AMRigel Announces Conference Call and Webcast to Report First Quarter 2024 Financial Results and Business Updateprnewswire.com - April 30 at 8:05 AMRigel Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)prnewswire.com - April 10 at 4:30 PMRigel Announces Publication of Data on REZLIDHIA® (Olutasidenib) in Post-Venetoclax Patients with Mutant IDH1 AML in Leukemia & Lymphomaprnewswire.com - April 4 at 8:05 AMAssenagon Asset Management S.A. Has $2.89 Million Stake in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)marketbeat.com - April 3 at 4:36 AMRigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Sees Large Growth in Short Interestmarketbeat.com - April 1 at 8:31 AMRigel Pharmaceuticals (NASDAQ:RIGL) Raised to "Buy" at StockNews.commarketbeat.com - March 27 at 11:16 PMRIGL Apr 2024 3.000 callfinance.yahoo.com - March 16 at 7:34 AMRigel Pharmaceuticals, Inc.: Rigel Pharmaceuticals Announces Appointment of Lisa Rojkjaer, M.D. as Chief Medical Officerfinanznachrichten.de - March 12 at 12:09 PMRigel Pharma Names Rojkjaer EVP, Chief Medical Officermarkets.businessinsider.com - March 12 at 12:09 PMRigel Pharmaceuticals Announces Appointment of Lisa Rojkjaer, M.D. as Chief Medical Officerprnewswire.com - March 12 at 8:05 AMRigel Pharmaceuticals (NASDAQ:RIGL) Upgraded at StockNews.commarketbeat.com - March 11 at 11:15 PMFY2024 Earnings Forecast for Rigel Pharmaceuticals, Inc. Issued By Cantor Fitzgerald (NASDAQ:RIGL)marketbeat.com - March 11 at 2:33 AMRigel Pharmaceuticals, Inc. (NASDAQ:RIGL) to Post Q1 2024 Earnings of ($0.01) Per Share, B. Riley Forecastsmarketbeat.com - March 8 at 6:19 AMRigel Pharmaceuticals Inc (RIGL) Reports Growth in 2023 Sales, Despite Net Loss for the Yearfinance.yahoo.com - March 7 at 6:17 PMRigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q4 2023 Earnings Call Transcriptinsidermonkey.com - March 7 at 1:01 PMCitigroup Raises Rigel Pharmaceuticals (NASDAQ:RIGL) Price Target to $4.00marketbeat.com - March 7 at 10:33 AMB. Riley Weighs in on Rigel Pharmaceuticals, Inc.'s Q1 2025 Earnings (NASDAQ:RIGL)marketbeat.com - March 7 at 7:38 AMRigel Pharmaceuticals Inc.barrons.com - March 6 at 10:15 PMRigel Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updatestockhouse.com - March 6 at 5:14 PMRigel Pharmaceuticals: Q4 Earnings Insightsbenzinga.com - March 6 at 5:14 PMRigel Pharmaceuticals Inc. Q4 Earnings Summarymarkets.businessinsider.com - March 6 at 5:14 PMRigel Pharmaceuticals GAAP EPS of $0.00 beats by $0.02, revenue of $35.8M beats by $2.39Mmsn.com - March 6 at 5:14 PMOwning 47% shares,institutional owners seem interested in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL),finance.yahoo.com - March 6 at 5:14 PMQ4 2023 Rigel Pharmaceuticals Inc Earnings Callfinance.yahoo.com - March 6 at 5:14 PMRigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Receives Consensus Rating of "Moderate Buy" from Analystsmarketbeat.com - March 6 at 1:52 PMRigel Pharmaceuticals (NASDAQ:RIGL) Given New $3.00 Price Target at Cantor Fitzgeraldmarketbeat.com - March 6 at 12:42 PMRigel Pharmaceuticals (NASDAQ:RIGL) Given "Buy" Rating at HC Wainwrightmarketbeat.com - March 6 at 9:45 AMQ4 2023 Rigel Pharmaceuticals Inc Earnings Call Transcriptgurufocus.com - March 6 at 12:03 AMRIGL Stock Earnings: Rigel Pharmaceuticals Beats Revenue for Q4 2023investorplace.com - March 5 at 9:01 PMRigel Announces Conference Call and Webcast to Report Fourth Quarter and Full Year 2023 Financial Results and Business Updateprnewswire.com - February 27 at 8:05 AMRigel Pharmaceuticals: Gavreto Deal Expands Growth Prospectsseekingalpha.com - February 26 at 6:28 PMBuy Rating for Rigel: Strategic Acquisitions and Market Positioning Fuel Revenue Growth Potentialmarkets.businessinsider.com - February 23 at 9:42 AMRIGL Mar 2024 1.500 putfinance.yahoo.com - February 23 at 12:52 AMRigel Pharmaceuticals Stock (NASDAQ:RIGL), Short Interest Reportbenzinga.com - February 22 at 7:52 PMRigel Pharma Acquires US Rights To Gavreto From Blueprint Medicines; Stock Up In Pre-Marketmarkets.businessinsider.com - February 22 at 9:51 AMRigel Pharmaceuticals Acquires U.S. Rights to GAVRETO®finance.yahoo.com - February 22 at 9:51 AMRigel Pharmaceuticals Acquires U.S. Rights to GAVRETO®prnewswire.com - February 22 at 7:50 AMCan Rigel Pharmaceuticals (RIGL) Beat Q4 Earnings Estimates?finance.yahoo.com - February 19 at 12:51 PM Get Rigel Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RIGL and its competitors with MarketBeat's FREE daily newsletter. Email Address Elon to Transform U.S. Economy? (Ad)A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth. One company holds a near-total monopoly on it. RIGL Media Mentions By Week RIGL Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RIGL News Sentiment▼-0.440.36▲Average Medical News Sentiment RIGL News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RIGL Articles This Week▼132▲RIGL Articles Average Week Get Rigel Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RIGL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Merrimack Pharmaceuticals News Regulus Therapeutics News Verastem News Emergent BioSolutions News Vanda Pharmaceuticals News XOMA News Lexicon Pharmaceuticals News Incannex Healthcare News Omeros News Generation Bio News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RIGL) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithDems have chosen Biden replacement?Paradigm Press348 million Americans lives to END as we know it?The Oxford ClubGold Set to EXPLODE!Gold Safe ExchangeObama’s Forever Term [exposed]Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rigel Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
